Search research articles
Contact Us
Filters
Showing results (221-230 of 237) with videos related to
Page
of 24
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
January 23, 2026
Phase I Clinical Trial of De-escalated Conformal Radiation Expedited Sequentially with Chemotherapy for Advanced Endometrial Cancer (DeCRESCEndo)
Joshua P Schiff, Silpa Raju-Salicki, Tyler R McKinnish, et al.
Molecular Cancer Research : MCR
|
August 1, 2023
Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix Proteins
Angela M Schab, Molly M Greenwade, Elizabeth Stock, et al.
Journal of the National Cancer Institute
|
April 5, 2017
Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence
Theodore M Brasky, Ashley S Felix, David E Cohn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 25, 2023
RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer
Amanda J Compadre, Lillian N van Biljon, Mark C Valentine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2025
Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201
Susana N Banerjee, Els Van Nieuwenhuysen, Carol Aghajanian, et al.
Infectious Agents and Cancer
|
May 2, 2026
Genomic and transcriptomic differences between neuroendocrine neoplasms and carcinomas with human papillomavirus (HPV)
Morgann Madill, Udhayvir Grewal, Harris Krause, et al.
NPJ Precision Oncology
|
November 4, 2023
In situ profiling reveals metabolic alterations in the tumor microenvironment of ovarian cancer after chemotherapy
Sara Corvigno, Sunil Badal, Meredith L Spradlin, et al.
Gynecologic Oncology
|
May 26, 2026
Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249
Lindsay M Kuroki, Danielle M Enserro, Heather A Lankes, et al.
Gynecologic Oncology
|
September 25, 2023
TP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomes
Karley Whelan, Mairead Dillon, Kyle C Strickland, et al.
Gynecologic Oncology
|
June 3, 2025
OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer
Premal H Thaker, Debra L Richardson, Andrea R Hagemann, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 237) with videos related to
Sort By:
Page
of 24
International Journal of Radiation Oncology, Biology, Physics
|
January 23, 2026
Phase I Clinical Trial of De-escalated Conformal Radiation Expedited Sequentially with Chemotherapy for Advanced Endometrial Cancer (DeCRESCEndo)
Joshua P Schiff, Silpa Raju-Salicki, Tyler R McKinnish, et al.
Molecular Cancer Research : MCR
|
August 1, 2023
Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix Proteins
Angela M Schab, Molly M Greenwade, Elizabeth Stock, et al.
Journal of the National Cancer Institute
|
April 5, 2017
Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence
Theodore M Brasky, Ashley S Felix, David E Cohn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 25, 2023
RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer
Amanda J Compadre, Lillian N van Biljon, Mark C Valentine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2025
Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201
Susana N Banerjee, Els Van Nieuwenhuysen, Carol Aghajanian, et al.
Infectious Agents and Cancer
|
May 2, 2026
Genomic and transcriptomic differences between neuroendocrine neoplasms and carcinomas with human papillomavirus (HPV)
Morgann Madill, Udhayvir Grewal, Harris Krause, et al.
NPJ Precision Oncology
|
November 4, 2023
In situ profiling reveals metabolic alterations in the tumor microenvironment of ovarian cancer after chemotherapy
Sara Corvigno, Sunil Badal, Meredith L Spradlin, et al.
Gynecologic Oncology
|
May 26, 2026
Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249
Lindsay M Kuroki, Danielle M Enserro, Heather A Lankes, et al.
Gynecologic Oncology
|
September 25, 2023
TP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomes
Karley Whelan, Mairead Dillon, Kyle C Strickland, et al.
Gynecologic Oncology
|
June 3, 2025
OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer
Premal H Thaker, Debra L Richardson, Andrea R Hagemann, et al.
Page
of 24